Johnson & Johnson Dividend: $10,000 Stake Yields $210 Annually

Dividend Streak and Yield

Johnson & Johnson (NYSE: JNJ) has increased its dividend for 64 consecutive years, placing it among the longest-running Dividend Kings—companies with at least 50 years of dividend growth. Only eight other Dividend Kings have longer streaks. The company's forward dividend yield stands at approximately 2.1%, which translates to about $210 annually for a $10,000 investment (roughly 39 shares at current prices).

Dividend Growth and Business Transformation

Over the past decade, Johnson & Johnson's dividend has grown by 67%, averaging about 5.3% per year. While this growth rate is moderate, the company has undergone significant strategic shifts since 2024, focusing on oncology through acquisitions such as Shockwave Medical, Intra-Cellular Therapies, Halda Therapeutics, and Firefly Bio. These moves have positioned J&J as a potential growth stock, with its share price gaining nearly 80% since the end of 2024. The company aims to achieve $50 billion in annual oncology drug sales by 2030.

For a detailed look at JNJ's dividend payments, see its dividend history. To calculate potential returns, use the dividend calculator.

What it means for income investors

Johnson & Johnson's long dividend streak and moderate yield offer a balance of income and growth potential. While the current yield is not the highest, the company's consistent increases and strategic pivot to oncology may support future dividend growth.

Reporting based on: Yahoo Finance. Figures verified against market data where available.